Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from INVO Fertility ( (IVF) ) is now available.
On June 25, 2025, INVO Fertility, Inc. held its annual meeting of stockholders where several proposals were voted on. The meeting was adjourned to July 9, 2025, to further solicit votes on a proposal to increase the number of authorized shares. Key approvals included the election of directors, ratification of the company’s accountant, and several stock issuance proposals under Nasdaq rules, which could impact the company’s capital structure and strategic flexibility.
The most recent analyst rating on (IVF) stock is a Buy with a $2.00 price target. To see the full list of analyst forecasts on INVO Fertility stock, see the IVF Stock Forecast page.
Spark’s Take on IVF Stock
According to Spark, TipRanks’ AI Analyst, IVF is a Underperform.
The overall stock score is primarily influenced by financial performance challenges, including significant operational losses and high leverage. Technical analysis further indicates bearish trends, while valuation metrics highlight negative investor sentiment due to losses and lack of dividends.
To see Spark’s full report on IVF stock, click here.
More about INVO Fertility
INVO Fertility, Inc. operates in the fertility industry, focusing on providing innovative fertility treatment solutions.
Average Trading Volume: 2,268,880
Technical Sentiment Signal: Sell
Current Market Cap: $2.16M
See more insights into IVF stock on TipRanks’ Stock Analysis page.